Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder
Joseph F. Goldberg(Icahn School of Medicine at Mount Sinai), Michael E. Thase(The University of Texas at San Antonio Health Science Center), Terence A. Ketter(Universidade Federal do Rio Grande do Sul), Keiko Kurita, Roy H. Perlis(Harvard University), Jennifer Hoblyn, David J. Miklowitz, S. Nassir Ghaemi(Tufts University), John O. Brooks
Cited by 142
Related Papers
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder
|Nature Genetics|2008|1.3k
Mood Disorders in the Medically Ill: Scientific Review and Recommendations
|Biological Psychiatry|2005|1.1k
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
|New England Journal of Medicine|2007|925
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754
Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): A systematic review
|Journal of Affective Disorders|2020|704